Biomedical Research Vocabulary in English

A biomarker is a measurable biological indicator — such as a gene, protein, metabolite, or imaging feature — that reflects a normal or abnormal biological process, disease state, or response to treatment. Biomarkers are used in diagnosis, to monitor disease progression, and to assess treatment efficacy. For example, elevated blood levels of troponin are a biomarker for heart muscle damage, while PSA is used as a biomarker in prostate cancer screening.

Peer review is the process by which a scientific paper is evaluated by independent experts in the same field before it is accepted for publication. Reviewers assess the study's methodology, statistical analysis, interpretation of results, and significance of findings. The process aims to catch errors, ensure rigour, and maintain quality standards in published science. Despite its importance, peer review is not infallible and has led to ongoing debates about how to reform the system.

A placebo-controlled trial is one in which some participants receive the actual treatment while others receive an inactive substance or sham procedure. Comparing outcomes between the groups allows researchers to determine how much of the observed effect is due to the treatment versus the psychological expectation of improvement. In double-blind trials, neither participants nor researchers know who has received the treatment until the study ends, reducing unconscious bias.

In vitro (Latin for 'in glass') refers to experiments conducted outside a living organism, typically in a laboratory setting using cell cultures, test tubes, or petri dishes. In vitro studies allow controlled investigation of biological processes and are often the first step in evaluating a new drug or compound. Results from in vitro studies do not always translate successfully to in vivo or clinical settings, which is why multiple stages of testing are required before a treatment reaches patients.

A randomised controlled trial (RCT) is considered the gold standard of clinical research. Participants are randomly assigned to either the intervention or control group, minimising selection bias. Randomisation means that differences in outcomes between groups can be more confidently attributed to the intervention rather than other factors. RCTs are required by regulatory agencies such as the FDA and EMA before approving new medical treatments.

A reagent is a substance used in a chemical or biological reaction to detect, measure, or produce other substances. In biomedical research, reagents include antibodies used in immunoassays, enzymes used in PCR amplification, and chemicals used in staining tissue samples. The quality and specificity of reagents are critical to experimental reproducibility. Poorly validated reagents have been identified as a significant contributor to the reproducibility crisis in biomedical science.

Statistical significance indicates that an observed result is unlikely to have occurred by chance alone, typically defined as a p-value below 0.05. A p-value of 0.05 means there is less than a 5% probability that the result occurred randomly. However, statistical significance does not necessarily mean clinical significance — a result can be statistically significant but too small to be practically meaningful. Researchers increasingly report effect sizes and confidence intervals alongside p-values.

Informed consent is the process by which a potential research participant is given clear, accurate information about a study and voluntarily agrees to take part. It is a fundamental ethical requirement in biomedical research, rooted in the principles established by the Nuremberg Code and the Declaration of Helsinki. Consent must be freely given without coercion, and participants must be able to withdraw at any time without penalty. Vulnerable populations require additional safeguards.

Focus first on methodology terms (randomised, blinded, placebo, cohort, p-value) and publication terms (peer review, abstract, protocol, reproducibility). Reading open-access articles on PubMed Central and following health journalism in outlets like The Lancet or BMJ online exposes you to these words in authentic contexts. The CONSORT and PRISMA reporting guidelines are excellent resources as they define key trial and systematic review terminology precisely. Use flash cards to memorise definitions, then practise writing brief research summaries using the new vocabulary.